Position in TBPH
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$778,082
-$139,026 QoQ
Shares Held
47,941
-2.2% QoQ
Ownership
0.093%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 23%
Shared 0%
None 77%
Common Shares in TBPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,189,862,767 across 287 Biotechnology names. TBPH ranks #124 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in TBPH
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $778,082 | 47,941 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $917,108 | 49,017 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $812,387 | 55,643 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $632,107 | 57,308 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $555,928 | 62,254 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $564,233 | 59,961 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $508,352 | 63,071 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $653,672 | 77,084 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $826,845 | 92,179 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,087,919 | 96,790 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $890,322 | 103,166 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,093,363 | 105,639 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $939 | 86,503 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $935 | 83,358 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $817,567 | 80,628 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $678,412 | 74,880 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $604,029 | 63,183 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $690,967 | 62,531 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $450,282 | 60,849 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $848,127 | 58,411 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $1,255,521 | 61,515 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $1,162,726 | 65,432 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $917,512 | 62,057 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,487,288 | 70,857 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,443,080 | 62,444 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||